CStone's MEK Inhibitor CS3006 Receives IND Approval in China |
| July 30, 2018 | July 2018 Bond Updates |
|
SUZHOU, China, July 30, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced that its IND application for CS3006, a small-molecule inhibitor of mitogen-activated protein kinase (MEK), has been approved by the China National Drug Administration (CNDA) for clinical trials,... |
| View more at: https://www.prnewswire.com:443/news-releases/cstones-mek-inhibitor-cs3006-receives-ind-approval-in-china-300688262.html |
| Related News |
|